Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 36261549
Chen B, et al. (2022) Gut bacteria alleviate smoking-related NASH by degrading gut nicotine. Nature 610, 562-568 36261549
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

T183-p - AMPKA1 (human)
Modsite: sDGEFLRtsCGsPNy SwissProt Entrez-Gene
Orthologous residues
AMPKA1 (human): T183‑p, AMPKA1 iso2 (human): T198‑p, AMPKA1 (mouse): T183‑p, AMPKA1 (rat): T183‑p, AMPKA1 (fruit fly): T184‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, modification-specific antibody, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  colorectal cancer, colorectal carcinoma, NAFLD
Relevant cell lines - cell types - tissues:  SW480 (intestinal)
Cellular systems studied:  cell lines
Species studied:  bacteria, human, mouse
Comments:  ileum mucosa biopsy, serum and stool samples were collected from 30 non-smokers and 30 smokers
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
cigarette_smoke increase low nicotine
cigarette_smoke cigarette_smoke augment treatment-induced increase high nicotine

K103-ub - SMPD3 (human)
Modsite: IYSRLEDkGLAGGAA SwissProt Entrez-Gene
Orthologous residues
SMPD3 (human): K103‑ub, SMPD3 (mouse): K103‑ub, SMPD3 (rat): K103‑ub
Characterization
Methods used to characterize site in vivo immunoprecipitation, modification-specific antibody, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  colorectal cancer, colorectal carcinoma, NAFLD
Relevant cell lines - cell types - tissues:  SW480 (intestinal)
Cellular systems studied:  cell lines
Species studied:  bacteria, human, mouse
Comments:  ileum mucosa biopsy, serum and stool samples were collected from 30 non-smokers and 30 smokers
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
cigarette_smoke decrease low nicotine
cigarette_smoke augment treatment-induced decrease high nicotine
Downstream Regulation
Effect of modification (function):  protein degradation

S209-p - SMPD3 (human)
Modsite: GsIKRTAsVEyKGDG SwissProt Entrez-Gene
Orthologous residues
SMPD3 (human): S209‑p, SMPD3 (mouse): S208‑p, SMPD3 (rat): S208‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, modification-specific antibody, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  colorectal cancer, colorectal carcinoma, NAFLD
Relevant cell lines - cell types - tissues:  SW480 (intestinal)
Cellular systems studied:  cell lines
Species studied:  bacteria, human, mouse
Comments:  ileum mucosa biopsy, serum and stool samples were collected from 30 non-smokers and 30 smokers
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE AMPKA1 (human) co-immunoprecipitation, pharmacological inhibitor of upstream enzyme, pharmacological activator of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
cigarette_smoke increase low nicotine
cigarette_smoke cigarette_smoke augment treatment-induced increase high nicotine
Downstream Regulation
Effect of modification (function):  protein stabilization
Comments:  phosphorylation of SMPD3 S208 inhibits degradation of K103-mediated degradation of SMPD3

K48-ub - ubiquitin (human)
Modsite: QRLIFAGkQLEDGRT SwissProt
Orthologous residues
ubiquitin (human): K48‑ub, ubiquitin (mouse): K48‑ub, ubiquitin (rat): K48‑ub, ubiquitin (cow): K48‑ub
Characterization
Methods used to characterize site in vivo immunoprecipitation, modification-specific antibody, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  colorectal cancer, colorectal carcinoma, NAFLD
Relevant cell lines - cell types - tissues:  SW480 (intestinal)
Cellular systems studied:  cell lines
Species studied:  bacteria, human, mouse
Comments:  ileum mucosa biopsy, serum and stool samples were collected from 30 non-smokers and 30 smokers
Downstream Regulation
Effect of modification (function):  protein degradation

T183-p - AMPKA1 (mouse)
Modsite: sDGEFLRtsCGsPNY SwissProt Entrez-Gene
Orthologous residues
AMPKA1 (human): T183‑p, AMPKA1 iso2 (human): T198‑p, AMPKA1 (mouse): T183‑p, AMPKA1 (rat): T183‑p, AMPKA1 (fruit fly): T184‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, modification-specific antibody, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  colorectal cancer, colorectal carcinoma, NAFLD
Relevant cell lines - cell types - tissues:  SW480 (intestinal)
Cellular systems studied:  cell lines
Species studied:  bacteria, human, mouse
Comments:  ileum mucosa biopsy, serum and stool samples were collected from 30 non-smokers and 30 smokers

K103-ub - SMPD3 (mouse)
Modsite: SYSRLEDkNPAGGAA SwissProt Entrez-Gene
Orthologous residues
SMPD3 (human): K103‑ub, SMPD3 (mouse): K103‑ub, SMPD3 (rat): K103‑ub
Characterization
Methods used to characterize site in vivo immunoprecipitation, modification-specific antibody, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  colorectal cancer, colorectal carcinoma, NAFLD
Relevant cell lines - cell types - tissues:  SW480 (intestinal)
Cellular systems studied:  cell lines
Species studied:  bacteria, human, mouse
Comments:  ileum mucosa biopsy, serum and stool samples were collected from 30 non-smokers and 30 smokers
Upstream Regulation
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
nicotine decrease nicotine water
B. xylanisolvens colonization nicotine inhibit treatment-induced decrease
Downstream Regulation
Effect of modification (function):  protein degradation

S208-p - SMPD3 (mouse)
Modsite: GsIKRTAsVEYKGDG SwissProt Entrez-Gene
Orthologous residues
SMPD3 (human): S209‑p, SMPD3 (mouse): S208‑p, SMPD3 (rat): S208‑p
Characterization
Methods used to characterize site in vivo immunoprecipitation, modification-specific antibody, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  colorectal cancer, colorectal carcinoma, NAFLD
Relevant cell lines - cell types - tissues:  SW480 (intestinal)
Cellular systems studied:  cell lines
Species studied:  bacteria, human, mouse
Comments:  ileum mucosa biopsy, serum and stool samples were collected from 30 non-smokers and 30 smokers
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE AMPKA1 (human) co-immunoprecipitation, pharmacological inhibitor of upstream enzyme, pharmacological activator of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
nicotine increase nicotine water
B. xylanisolvens colonization nicotine inhibit treatment-induced increase
Downstream Regulation
Effect of modification (function):  protein stabilization
Comments:  phosphorylation of SMPD3 S208 inhibits degradation of K103-mediated degradation of SMPD3

K48-ub - ubiquitin (mouse)
Modsite: QRLIFAGkQLEDGRT SwissProt
Orthologous residues
ubiquitin (human): K48‑ub, ubiquitin (mouse): K48‑ub, ubiquitin (rat): K48‑ub, ubiquitin (cow): K48‑ub
Characterization
Methods used to characterize site in vivo immunoprecipitation, modification-specific antibody, mutation of modification site, phospho-antibody, western blotting
Disease tissue studied:  colorectal cancer, colorectal carcinoma, NAFLD
Relevant cell lines - cell types - tissues:  SW480 (intestinal)
Cellular systems studied:  cell lines
Species studied:  bacteria, human, mouse
Comments:  ileum mucosa biopsy, serum and stool samples were collected from 30 non-smokers and 30 smokers
Downstream Regulation
Effect of modification (function):  protein degradation